Login
$GUTS
$0.88 -$0.19 (17.76%) Close

Company Executives

$GUTS Management Team

Mr. Ajay Royan

Independent Chairman of the Board

Age 45
Compensation $449.4K USD
Sex Male

Mr. Jay Caplan

President

Co-Founder

Chief Product Officer

Age 63
Compensation $2.199M USD
Sex Male

Dr. Harith Rajagopalan

Chief Executive Officer

Co-Founder

Director

Age 48
Compensation $4.856M USD
Sex Male

Dr. Timothy Kieffer

Chief Scientific Officer

Age 59
Compensation $3.462M USD
Sex Male

Ms. Sarah Toomey

General Counsel

Corporate Secretary

Age 50
Compensation $1.489M USD
Sex Female

Ms. Lara Weber

Chief Financial Officer

Age -
Compensation -
Sex Female
Directors
9
serving now
Independent
8 of 8
stated in the proxy; 1 not stated
Average tenure
6.0 years
from year joined
CEO also chairs the board
No
Ajay Royan
Director Age On board Independent Committees Other public boards 2025 pay Source
Marc Elia
50 2021
5 years
Independent None stated Invivyd, Inc. (previously Adagio Therapeutics, Inc.) $82,479
Clive Meanwell, M.B., Ch.B., M.D.
68 2021
5 years
Independent
Compensation and Human Strategy Committee · Chair
None stated $88,267
Ian Sheffield
49 2025
1 year
Independent
Audit Committee
None stated $30,567
William W. Bradley
82 2017
9 years
Independent
Nominating and Corporate Governance Committee · Chair
None stated $83,267
Ajay Royan
46 2014
12 years
Independent
Audit Committee
Invivyd, Inc. (previously Adagio Therapeutics, Inc.) $123,267
Christopher C. Thompson, M.D., MSc
56 2025
1 year
Independent None stated None stated $29,779
Kelly Barnes
60 2022
4 years
Independent
Audit Committee · Chair
None stated $100,767
Samuel Conaway
61 2024
2 years
Independent
Compensation and Human Strategy Committee
None stated $80,767
Harith Rajagopalan, M.D., Ph.D.
49 2011
15 years
Not stated None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support